Stocks 323 records
| Ticker | Company | Sector | Price | Revenue Estimate | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | MERCK KGAA I | Healthcare | 137.85 € | 59.93B | 26.11 | 15.46 | 1.57% | -3.18% | +10.69% | +13.04% | FY Cur +1.78% (14) Q Cur +0.89% (3) FY Next +5.43% (14) Q Next +0.60% (3) | |
 | Takeda Pharmaceutical Company L | Healthcare | $18.73 ≈ 16.72 € | 53.4B | - | - | 3.33% | +0.82% | +18.49% | +29.42% | FY Cur +1.78% (16) Q Cur +3.56% (6) FY Next +1.85% (16) Q Next +6.21% (6) | |
 | TAKEDA PHARMACEUTICAL CO LTD | Healthcare | ¥5,843 ≈ 32.95 € | 52.63B | - | - | 3.51% | +0.46% | +20.85% | +34.76% | FY Cur +1.78% (16) Q Cur +3.56% (6) FY Next +1.85% (16) Q Next +6.21% (6) | |
 | Teva Pharmaceutical Industries | Healthcare | $41.10 ≈ 36.68 € | 42.78B | 68.5 | 13.29 | 0.00% | +0.18% | +25.24% | +94.21% | FY Cur -3.49% (13) Q Cur -5.41% (11) FY Next +3.61% (13) Q Next -0.28% (11) | |
 | JIANGSU HENGRUI PHARMACEUTICALS | Healthcare | ¥46.85 ≈ 6.24 € | 41.43B | 40.39 | 30.43 | 0.38% | -0.34% | -22.15% | -34.15% | FY Cur +6.26% (16) Q Cur +23.52% (2) FY Next +15.16% (18) Q Next -2.77% (2) | |
 | GALDERMA GROUP N | Healthcare | 164.95 CHF ≈ 177.29 € | 41.34B | 56.88 | 24.66 | 0.22% | +1.32% | +1.76% | +12.13% | FY Cur +23.20% (14) Q Cur +21.41% (2) FY Next +17.02% (17) Q Next +10.86% (1) | |
 | TEVA PHARMA IND | Healthcare | 12,000.00 Agorot ≈ 34.90 € | 40.7B | 62.83 | - | 0.00% | -1.83% | +16.88% | +75.38% | FY Cur -3.49% (13) Q Cur -5.41% (11) FY Next +3.61% (13) Q Next -0.28% (11) | |
 | SUN PHARMACEUTICAL IND L | Healthcare | ₹1,760.00 ≈ 16.22 € | 38.92B | 34.92 | 27.16 | 0.91% | -1.19% | +2.3% | +7.86% | FY Cur +11.39% (33) Q Cur +9.95% (15) FY Next +12.02% (29) Q Next +8.59% (3) | |
 | HALEON PLC ORD GBP0.01 | Healthcare | 349.20 p ≈ 4.13 € | 36.28B | 19.4 | 1.53K | 2.12% | +0.55% | -7.84% | +1.03% | FY Cur +3.26% (16) Q Cur +4.06% (2) FY Next +4.19% (16) Q Next -1.77% (2) | |
 | HENGRUI PHARMA | Healthcare | HK$ 48.00 ≈ 5.46 € | 36.23B | 37.5 | 33.61 | 0.42% | -0.91% | -32.68% | -45.33% | FY Cur +6.26% (16) Q Cur +23.52% (2) FY Next +15.16% (18) Q Next -2.77% (2) | |
 | Haleon PLC R | Healthcare | 8.10 € | 35.62B | 19.29 | - | 2.20% | +3.87% | -4.73% | +5.92% | FY Cur +3.26% (16) Q Cur +4.06% (2) FY Next +4.19% (16) Q Next -1.77% (2) | |
 | SANDOZ GROUP N | Healthcare | 69.72 CHF ≈ 74.94 € | 32.42B | 59.59 | 15.22 | 1.15% | +0.58% | +20.54% | +40.88% | FY Cur +9.16% (14) Q Cur +7.15% (2) FY Next +5.31% (14) Q Next +11.53% (1) | |
 | Zoetis Inc. | Healthcare | $74.81 ≈ 66.77 € | 27.59B | 12.3 | 11.43 | 2.90% | +2.14% | -42.19% | -49.07% | FY Cur -2.43% (13) Q Cur -4.22% (11) FY Next +2.60% (15) Q Next -3.28% (10) | |
 | DIVI S LABORATORIES LTD | Healthcare | ₹9,340.00 ≈ 86.09 € | 22.85B | 84.75 | 61.84 | 0.32% | -0.22% | +46.84% | +52.32% | FY Cur +19.09% (29) Q Cur +18.39% (14) FY Next +19.32% (28) Q Next -8.46% (3) | |
 | HANSOH PHARMA | Healthcare | HK$ 31.54 ≈ 3.59 € | 21.74B | 25.23 | 28.06 | 1.51% | -1.99% | -14.06% | -14.8% | FY Cur +13.09% (22) Q Cur - (0) FY Next +9.69% (24) Q Next - (0) | |
 | United Therapeutics Corporation | Healthcare | $549.16 ≈ 490.13 € | 21.02B | 19.67 | 16.25 | 0.00% | -2.24% | +7.37% | +18.68% | FY Cur -0.74% (14) Q Cur -1.87% (13) FY Next +12.09% (14) Q Next +2.94% (13) | |
 | Viatris Inc. | Healthcare | $17.64 ≈ 15.74 € | 18.08B | - | 6.6 | 2.75% | -0.29% | +39.07% | +74.92% | FY Cur +3.44% (9) Q Cur +1.07% (9) FY Next +1.68% (9) Q Next -2.18% (9) | |
 | TORRENT PHARMACEUTICALS L | Healthcare | ₹4,656.90 ≈ 42.92 € | 16.33B | 74.39 | 49.92 | 0.82% | -2.1% | +20.8% | +29.37% | FY Cur +41.73% (27) Q Cur +48.55% (10) FY Next +12.59% (27) Q Next +0.92% (3) | |
 | PHARMAESSENTIA CORP | Healthcare | NT$ 1,195.00 ≈ 33.42 € | 13.8B | 68.8 | 28.95 | 0.12% | -0.83% | +180.55% | +145.93% | FY Cur +82.83% (5) Q Cur +95.11% (4) FY Next +45.22% (6) Q Next +15.28% (4) | |
 | Swedish Orphan Biovitrum AB | Healthcare | 428.40 kr ≈ 38.05 € | 13.24B | 111.56 | 18.84 | 0.00% | -2.54% | +26.92% | +35.3% | FY Cur +17.12% (10) Q Cur +14.55% (5) FY Next +12.26% (10) Q Next +2.48% (4) | |
 | SHIONOGI & CO | Healthcare | ¥2,745 ≈ 15.48 € | 13.17B | 8.94 | - | 2.74% | -0.88% | -3.4% | +8.01% | FY Cur +26.20% (12) Q Cur +54.95% (5) FY Next +4.42% (11) Q Next +7.26% (5) | |
 | Neurocrine Biosciences, Inc. | Healthcare | $142.44 ≈ 127.13 € | 12.92B | 20.89 | 11.99 | 0.00% | -1.55% | +0.21% | +1.56% | FY Cur +36.44% (25) Q Cur +31.46% (23) FY Next +16.61% (24) Q Next +3.90% (22) | |
 | SICHUAN BIOKIN PHARMACEUTICAL C | Healthcare | ¥229.33 ≈ 30.56 € | 12.62B | - | - | 0.00% | +0.98% | -28.93% | -37.43% | FY Cur +0.02% (2) Q Cur - (0) FY Next +34.02% (1) Q Next - (0) | |
 | YUNNAN BAIYAO | Healthcare | ¥51.40 ≈ 6.85 € | 12.22B | 17.42 | 15.87 | 3.11% | +1% | -9.73% | -10.36% | FY Cur +3.17% (11) Q Cur +8.44% (1) FY Next +4.11% (12) Q Next +1.62% (1) | |
 | IPSEN | Healthcare | 142.70 € | 11.76B | 23.09 | 10.24 | 1.13% | -2.41% | +18.91% | +20.73% | FY Cur +16.82% (11) Q Cur +22.39% (2) FY Next +2.11% (12) Q Next -2.41% (1) | |
 | NHU | Healthcare | ¥26.58 ≈ 3.54 € | 10.89B | 11.26 | 9.64 | 3.80% | +1.03% | +5.73% | +6.07% | FY Cur +19.18% (9) Q Cur +18.76% (1) FY Next +3.55% (9) Q Next +0.00% (1) | |
 | ZYDUS LIFESCIENCES LTD | Healthcare | ₹1,117.50 ≈ 10.30 € | 10.27B | 24.91 | 22.71 | 0.09% | -3.56% | +23.36% | +12.78% | FY Cur +16.98% (26) Q Cur +23.05% (10) FY Next +10.82% (25) Q Next +5.32% (3) | |
 | Elanco Animal Health Incorporat | Healthcare | $22.92 ≈ 20.46 € | 10.22B | - | 17.84 | 0.00% | +0.81% | -0.97% | +10.82% | FY Cur +8.66% (12) Q Cur +5.96% (10) FY Next +5.29% (12) Q Next -1.64% (9) | |
 | LAURUS LABS LIMITED | Healthcare | ₹2,036.60 ≈ 18.77 € | 10.14B | 100.67 | 69.05 | 0.12% | +1.94% | +86.52% | +135.42% | FY Cur +22.61% (12) Q Cur +27.22% (8) FY Next +15.21% (13) Q Next -2.68% (2) | |
 | CIPLA LTD | Healthcare | ₹1,301.00 ≈ 11.99 € | 9.69B | 31.34 | 20.53 | 0.99% | -0.44% | -12.83% | -14.02% | FY Cur +9.83% (36) Q Cur +0.41% (15) FY Next +12.13% (35) Q Next +5.21% (4) | |
 | Dr. Reddy's Laboratories Ltd | Healthcare | $12.48 ≈ 11.14 € | 9.28B | 28.36 | 0.2 | 0.68% | -0.57% | -13.23% | -12.79% | FY Cur +4.75% (35) Q Cur -2.37% (19) FY Next +11.69% (33) Q Next +4.53% (5) | |
 | DR. REDDY S LABORATORIES | Healthcare | ₹1,197.00 ≈ 11.03 € | 9.19B | 30.12 | 20.36 | 0.68% | +1.44% | -5.44% | -3.94% | FY Cur +4.75% (35) Q Cur -2.37% (19) FY Next +11.69% (33) Q Next +4.53% (5) | |
 | MANKIND PHARMA LIMITED | Healthcare | ₹2,368.50 ≈ 21.83 € | 9.02B | 50.34 | 33.45 | 0.00% | -4.8% | +10.57% | -3.05% | FY Cur +12.51% (19) Q Cur +12.47% (7) FY Next +11.60% (18) Q Next -3.41% (1) | |
 | AUROBINDO PHARMA LTD | Healthcare | ₹1,693.00 ≈ 15.60 € | 8.98B | 26.45 | 18.12 | 0.00% | +2.92% | +42.71% | +51.17% | FY Cur +19.12% (26) Q Cur +18.66% (11) FY Next +10.92% (26) Q Next +5.03% (4) | |
 | SHANGHAI FOSUN PHARMACEUTICAL G | Healthcare | ¥23.89 ≈ 3.18 € | 8.5B | 18.52 | 21.72 | 1.64% | +0.55% | -9.71% | -19.94% | FY Cur +2.07% (5) Q Cur +3.94% (1) FY Next +3.19% (6) Q Next +6.83% (1) | |
 | LUPIN LIMITED | Healthcare | ₹1,956.50 ≈ 18.03 € | 8.25B | 16.21 | 19.23 | 0.93% | +1.01% | -5.96% | -0.06% | FY Cur +8.29% (34) Q Cur +9.33% (14) FY Next +6.50% (33) Q Next -2.61% (3) | |
 | EISAI CO LTD | Healthcare | ¥4,603 ≈ 25.96 € | 7.33B | 33.86 | - | 3.45% | -0.6% | -1.22% | -2.44% | FY Cur +6.39% (14) Q Cur +12.05% (6) FY Next +6.38% (13) Q Next +8.51% (6) | |
 | KYOWA KIRIN CO LTD | Healthcare | ¥2,223 ≈ 12.53 € | 6.56B | 14.22 | - | 3.17% | +0.61% | -12.05% | -5.87% | FY Cur +0.14% (11) Q Cur +3.99% (5) FY Next +1.85% (11) Q Next +16.15% (5) | |
 | Hims & Hers Health, Inc. | Healthcare | $30.92 ≈ 27.60 € | 6.44B | - | 41.94 | 0.00% | -5.01% | -15.07% | -51.76% | FY Cur +36.65% (14) Q Cur +49.05% (13) FY Next +24.59% (14) Q Next +6.92% (13) | |
 | HD MEDICINE | Healthcare | ¥27.29 ≈ 3.64 € | 6.38B | 13.65 | 10.85 | 3.45% | +1.26% | -30.13% | -34.62% | FY Cur +2.90% (8) Q Cur +1.81% (1) FY Next +4.07% (9) Q Next +1.85% (1) | |
 | Amneal Pharmaceuticals, Inc. | Healthcare | $19.91 ≈ 17.77 € | 6.19B | 40.63 | 16.7 | 0.00% | 0% | +52.56% | +87.5% | FY Cur +4.53% (6) Q Cur +3.52% (6) FY Next +9.13% (6) Q Next +1.56% (6) | |
 | H. Lundbeck A/S B | Healthcare | 45.96 kr ≈ 6.14 € | 6.1B | 11.72 | 7.42 | 2.49% | +2.31% | +6.86% | +0.83% | FY Cur +5.04% (12) Q Cur +1.69% (8) FY Next +0.89% (12) Q Next -5.85% (7) | |
 | Alkermes plc | Healthcare | $40.61 ≈ 36.24 € | 6.08B | 106.87 | 22.46 | 0.00% | -3.23% | +44.23% | +27.29% | FY Cur +23.54% (18) Q Cur +17.95% (17) FY Next +6.53% (18) Q Next +1.55% (17) | |
 | GLENMARK PHARMACEUTICALS | Healthcare | ₹2,293.00 ≈ 21.13 € | 5.96B | 36 | 23.62 | 0.11% | -3.95% | +8% | +13.63% | FY Cur -0.88% (9) Q Cur -31.96% (3) FY Next +11.27% (9) Q Next -100.00% (0) | |
 | Lantheus Holdings, Inc. | Healthcare | $100.15 ≈ 89.38 € | 5.84B | 24.25 | 15.7 | 0.00% | -0.06% | +49.08% | +86.97% | FY Cur -2.74% (4) Q Cur -5.83% (6) FY Next +10.29% (10) Q Next +1.79% (6) | |
 | ALKEM LABORATORIES LTD. | Healthcare | ₹5,279.00 ≈ 48.66 € | 5.82B | 29.26 | 23.59 | 0.38% | -1.89% | -4.01% | -4.44% | FY Cur +13.49% (21) Q Cur +12.11% (9) FY Next +11.40% (20) Q Next -7.11% (2) | |
 | H. Lundbeck A/S A | Healthcare | 43.80 kr ≈ 5.85 € | 5.81B | 11.17 | - | 2.62% | +0.92% | +21.13% | +21.3% | FY Cur +5.04% (12) Q Cur +1.69% (8) FY Next +0.89% (12) Q Next -5.85% (7) | |
 | CR SANJIU | Healthcare | ¥24.82 ≈ 3.31 € | 5.5B | 12.6 | 10.2 | 4.25% | +1.39% | -13.03% | -12.27% | FY Cur +5.45% (11) Q Cur +3.88% (1) FY Next +6.74% (11) Q Next +33.39% (1) | |
 | Kiniksa Pharmaceuticals Interna | Healthcare | $79.78 ≈ 71.20 € | 5.48B | 79.78 | 49.32 | 0.00% | +1.01% | +92.12% | +105.56% | FY Cur +46.66% (8) Q Cur +43.54% (8) FY Next +22.90% (8) Q Next +6.37% (8) | |
 | FOSUN PHARMA | Healthcare | HK$ 17.87 ≈ 2.03 € | 5.43B | 12.5 | - | 2.53% | +0.28% | -8.69% | -29.92% | FY Cur +2.07% (5) Q Cur +3.94% (1) FY Next +3.19% (6) Q Next +6.83% (1) |
Rows per page:
Page 1 of 7
Results: 323
CNMkt Cap
41.43B
P/E 40.39
-34.15% 1Y
INMkt Cap
16.33B
P/E 74.39
+29.37% 1Y
CNMkt Cap
12.62B
P/E -
-37.43% 1Y
CNMkt Cap
8.5B
P/E 18.52
-19.94% 1Y
Results 1 - 50 of 323
Per page:
Page 1 / 7